|
Treatment
Options > Who
Should Be Treated > AASLD Practice Guidelines
Who Should Be Treated
AASLD Practice Guidelines
Two of the nation's leading liver specialists, Anna Lok, M.D.,
and Brian McMahon, M.D., developed practice guidelines for chronic
hepatitis B that were first approved by the American Association
for the Study of Liver Diseases (AASLD) in 2001, and published in
Hepatology, a medical journal for liver diseases.
In light of new advances in the field, these guidelines were updated
in the fall of 2003, spring 2004, and October 2007.
Drs. Lok and McMahon provide an excellent review of the current
state of knowledge in hepatitis B. Their conclusion answers the
important treatment questions as to who should be treated and with
what therapies based on all the available evidence.
For more information, read the AASLD Guidelines:
- AASLD Practice Guidelines 2007
- AASLD Practice Guidelines 2004
- AASLD Practice Guidelines 2003
- AASLD Practice Guidelines 2001
|
HBF Drug Watch
With promising new compounds in development
for hepatitis B, there is great hope that a cure will be found in the near
future. Visit the HBF Drug
Watch for a complete list of approved hepatitis
B drugs and compounds in development, as well as our list of Hepatitis
B Clinical Trials.
Download Our Information Sheet:
 Hepatitis
B Treatment
|
